ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1866

Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis

Debbie Ehrmann Feldman1, Evelyne Vinet2, Sasha Bernatsky3, Ciaran Duffy4, Elizabeth Hazel5, Marie-Pierre Sylvestre6, Garbis Meshefedjian7 and Anick Bérard1, 1Université de Montréal, Montréal, QC, Canada, 2McGill University Health Center, Montreal, QC, Canada, 3Clinical Epidemiology - Rheumatology, McGill University, Montreal, QC, Canada, 4Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, 5McGill University Heatlh Center, Montreal, QC, Canada, 6médecine sociale et préventive, Université de Montréal, Montréal, QC, Canada, 7Public Health Department of Montreal, Montreal, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), outcomes and pregnancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

Session Type: Combined Abstract Sessions

Background/Purpose: Although there is a higher frequency of adverse birth outcomes in women with rheumatoid arthritis, little is known on the subject regarding women who had juvenile idiopathic arthritis ( JIA) as children or adolescents.  The objective of our study was to determine whether children born to women who had JIA in childhood and adolescence had more adverse birth outcomes than children born to mothers who never had JIA.

Methods: We designed a retrospective cohort study using administrative data that covered the entire population of the province of Québec, Canada. We identified 1756 females with a diagnosis of JIA who had given birth (first birth: stillbirth or live birth) between 01/01/1983 and 12/31/2010 from the Quebec physician reimbursement and hospitalization databases. We also assembled a cohort of women from the population database who did not have a diagnosis of JIA,  matched 4:1 for date of first birth (± 3 months), age (± 5 years) and region of residence (using the postal code) to serve as a control group (n=7024). We compared birth outcomes (stillbirth, prematurity, small for gestational age, and the presence of major congenital anomalies diagnosed within the first year post birth) in those who had JIA and those who did not. We used logistic regression, adjusting for maternal age, sex of the infant, maternal education, hypertension during pregnancy and gestational diabetes.

Results: For the entire cohort, the mean age at delivery was 24.9 years (standard deviation 4.4; range 16 to 46 years). There were more adverse birth outcomes in the JIA group, except for stillbirths. Women who had had JIA were at higher risk for having a premature baby (adjusted relative risk (95% confidence interval) 1.18 (1.00,1.4)), a small for gestational age baby (adjusted relative risk (95% confidence interval) 1.19 (1.04-1.36)), and a child with a major congenital anomaly (adjusted relative risk (95% confidence interval) 6.49 (4.88-8.10)). The prevalence of neural tube defects was especially high in the JIA group (1.7% vs 0.04% in the non JIA group) as were congenital heart and circulatory defects (1.2% in the JIA group vs 0.6% in the non JIA group).

Conclusion: Women who had JIA are at higher risk for adverse birth outcomes.  The implications are that women with a history of JIA who are pregnant must be monitored closely. Further research is needed to understand possible pathophysiologic mechanisms in JIA and pregnancy as well as pharmaco-epidemiologic studies to explore the effects of medications during childhood and youth (including during the peri-pubescent period) on future birth outcomes.


Disclosure:

D. Ehrmann Feldman,
None;

E. Vinet,
None;

S. Bernatsky,
None;

C. Duffy,
None;

E. Hazel,
None;

M. P. Sylvestre,
None;

G. Meshefedjian,
None;

A. Bérard,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/birth-outcomes-in-women-with-a-history-of-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology